High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on ...

Bristol Myers Squibb (BMY) wins dismissal of a lawsuit filled by Blue Cross Blue Shield of Louisiana alleging antitrust trust ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

In Bristol Myers' case, the company incurred $13.4 billion in acquired in-process research and development costs, which relates to its acquisition of Karuna and a collaboration with SystImmune.

Ericsson joining Avanci Video as a licensor and the EUIPO's plans for AI use were also among the top talking points this week ...

A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 37,216 calls trading, 3x expected, and implied vol increasing almost 3 points to 39.30%. Jan-26 25 calls and May-25 43 calls are the ...

As you can see from the chart above the percentage of shares that are sold short for Bristol-Myers Squibb has grown since its last report. This does not mean that the stock is going to fall in the ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...